Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01450397 · ClinicalTrials.gov registry record · Phase 4
MRI Results in Dupuytren's Contracture Before and After Injection With Xiaflex
A Phase 4 study of Dupuytren's Disease, sponsored by Hospital for Special Surgery, New York.
- Completed
- Registry status
- Phase 4
- Development phase
- 5
- Enrollment target
- 1
- Study location
NCT01450397: Completed Phase 4 study of Dupuytren's Disease, sponsored by Hospital for Special Surgery, New York.
NCT01450397 is a Phase 4 study of Dupuytren's Disease that has completed, run by Hospital for Special Surgery, New York. The registered enrollment target is 5 participants, below the 61-participant average among 4 other Dupuytren's Disease trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01450397, a Phase 4 study of Dupuytren's Disease, has completed, sponsored by Hospital for Special Surgery, New York.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 5 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the effects of XIAFLEX on your finger through MRI.
Primary Outcome
Change in Volume (millimeter cubed) of the Cord by MRI between Baseline and 30 days after XIAFLEX injection and manual manipulation.
Conditions Studied
Interventions
- BIOLOGICAL XIAFLEX
Study Locations (1)
New York
- Hosptial for Special Surgery - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2011-03 |
| Est. Completion | 2012-02 |
| Phase | Phase 4 |
What the finished NCT01450397 record still lists
NCT01450397 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 61-participant average among 4 other Dupuytren's Disease trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Dupuytren's Disease appearing as the primary indexed condition, and to 1 intervention - of which XIAFLEX is the first listed.
NCT01450397 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT01450397 about?
NCT01450397 is a clinical study titled "MRI Results in Dupuytren's Contracture Before and After Injection With Xiaflex". The purpose of this study is to determine the effects of XIAFLEX on your finger through MRI.
What is the current status of trial NCT01450397?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 5 participants. The study started on 2011-03. Estimated completion is 2012-02.
What conditions does trial NCT01450397 study?
This clinical trial studies the following conditions: Dupuytren's Disease.
What interventions are being tested in trial NCT01450397?
The interventions under investigation include: XIAFLEX (BIOLOGICAL).
Who is sponsoring clinical trial NCT01450397?
This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01450397 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dupuytren's Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Post-contracture Release Radiation for Dupuytren's Disease
RECRUITING
-
Collagenase in the Treatment of Dupuytrens Disease
COMPLETED · Phase 3
-
Effectiveness of Splinting After Collagenase Injection
COMPLETED · Phase 3
-
Phase 2a Dose-Ranging Study to Evaluate Safety and Effectiveness of AA4500 in Treatment of Dupuytren's Disease Nodules
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia